PAVMED INC. news, videos and press releases
For more news please use our advanced search feature.
PAVMED INC. - More news...
PAVMED INC. - More news...
- PAVmed to Hold a Business Update Conference Call and Webcast on March 25, 2025
- PAVmed and Subsidiary Veris Health Complete Private Placement Financing
- PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement
- PAVmed Provides Business Update and Third Quarter 2024 Financial Results
- PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024
- PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care
- PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements
- PAVmed Provides Business Update and Second Quarter 2024 Financial Results
- PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024
- PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
- PAVmed Provides Business Update and First Quarter 2024 Financial Results
- PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024
- PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
- PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
- PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX
- PAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024
- PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders
- PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split
- PAVmed Provides Business Update and Third Quarter Financial Results
- PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2023
- PAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference
- PAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference
- PAVmed Provides Business Update and Second Quarter Financial Results
- PAVmed to Hold a Business Update Conference Call and Webcast on August 16, 2023
- PAVmed and Lucid Chairman and Chief Executive Officer, Dr. Lishan Aklog, Testifies at U.S. House of Representatives Energy and Commerce Committee, Hearing on Life-Saving Innovations and Medicare Coverage
- PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement
- PAVmed to Participate in Healthcare Virtual Conference Presented by Maxim Group LLC
- PAVmed Digital Health Subsidiary, Veris Health, Joins Cancer Moonshot's CancerX Partnership as Founding Member
- PAVmed Provides Business Update and First Quarter Financial Results
- PAVmed to Hold a Business Update Conference Call and Webcast on May 17, 2023
